BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: American College of Medical Genetics and Genomics. Incidental findings in clinical genomics: a clarification. Genet Med 2013;15:664-6. [DOI: 10.1038/gim.2013.82] [Cited by in Crossref: 95] [Cited by in F6Publishing: 89] [Article Influence: 10.6] [Reference Citation Analysis]
Number Citing Articles
1 Nishimura AA, Tarczy-Hornoch P, Shirts BH. Pragmatic and Ethical Challenges of Incorporating the Genome into the Electronic Medical Record. Curr Genet Med Rep 2014;2:201-11. [PMID: 26146597 DOI: 10.1007/s40142-014-0051-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
2 McCullough LB, Brothers KB, Chung WK, Joffe S, Koenig BA, Wilfond B, Yu JH; Clinical Sequencing Exploratory Research (CSER) Consortium Pediatrics Working Group. Professionally Responsible Disclosure of Genomic Sequencing Results in Pediatric Practice. Pediatrics 2015;136:e974-82. [PMID: 26371191 DOI: 10.1542/peds.2015-0624] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
3 Modell SM, Citrin T, Kardia SLR. Laying Anchor: Inserting Precision Health into a Public Health Genetics Policy Course. Healthcare (Basel) 2018;6:E93. [PMID: 30081448 DOI: 10.3390/healthcare6030093] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
4 Sabatello M, Appelbaum PS. Raising Genomic Citizens: Adolescents and the Return of Secondary Genomic Findings. J Law Med Ethics 2016;44:292-308. [PMID: 27338605 DOI: 10.1177/1073110516654123] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
5 Gutmann A. Ethics. The bioethics commission on incidental findings. Science 2013;342:1321-3. [PMID: 24337279 DOI: 10.1126/science.1248764] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
6 Ross LF, Clayton EW. Ethical Issues in Newborn Sequencing Research: The Case Study of BabySeq. Pediatrics 2019;144:e20191031. [PMID: 31719124 DOI: 10.1542/peds.2019-1031] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
7 Gornick MC, Scherer AM, Sutton EJ, Ryan KA, Exe NL, Li M, Uhlmann WR, Kim SY, Roberts JS, De Vries RG. Effect of Public Deliberation on Attitudes toward Return of Secondary Results in Genomic Sequencing. J Genet Couns 2017;26:122-32. [PMID: 27307100 DOI: 10.1007/s10897-016-9987-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
8 Kesserwan C, Friedman Ross L, Bradbury AR, Nichols KE. The Advantages and Challenges of Testing Children for Heritable Predisposition to Cancer. Am Soc Clin Oncol Educ Book 2016;35:251-69. [PMID: 27249705 DOI: 10.1200/EDBK_160621] [Cited by in Crossref: 12] [Cited by in F6Publishing: 2] [Article Influence: 2.4] [Reference Citation Analysis]
9 Sénécal K, Thys K, Vears DF, Van Assche K, Knoppers BM, Borry P. Legal approaches regarding health-care decisions involving minors: implications for next-generation sequencing. Eur J Hum Genet 2016;24:1559-64. [PMID: 27302841 DOI: 10.1038/ejhg.2016.61] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
10 Burke W, Antommaria AH, Bennett R, Botkin J, Clayton EW, Henderson GE, Holm IA, Jarvik GP, Khoury MJ, Knoppers BM, Press NA, Ross LF, Rothstein MA, Saal H, Uhlmann WR, Wilfond B, Wolf SM, Zimmern R. Recommendations for returning genomic incidental findings? We need to talk! Genet Med 2013;15:854-9. [PMID: 23907645 DOI: 10.1038/gim.2013.113] [Cited by in Crossref: 209] [Cited by in F6Publishing: 194] [Article Influence: 23.2] [Reference Citation Analysis]
11 Ploug T, Holm S. Clinical genome sequencing and population preferences for information about 'incidental' findings-From medically actionable genes (MAGs) to patient actionable genes (PAGs). PLoS One 2017;12:e0179935. [PMID: 28671958 DOI: 10.1371/journal.pone.0179935] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
12 Roche MI, Berg JS. Incidental Findings with Genomic Testing: Implications for Genetic Counseling Practice. Curr Genet Med Rep 2015;3:166-76. [PMID: 26566463 DOI: 10.1007/s40142-015-0075-9] [Cited by in Crossref: 57] [Cited by in F6Publishing: 48] [Article Influence: 8.1] [Reference Citation Analysis]
13 Su X, Kang PB, Russell JA, Simmons Z. Ethical issues in the evaluation of adults with suspected genetic neuromuscular disorders. Muscle Nerve 2016;54:997-1006. [PMID: 27615030 DOI: 10.1002/mus.25400] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Warren-Gash C, Kroese M, Burton H, Pharoah P. Implications of using whole genome sequencing to test unselected populations for high risk breast cancer genes: a modelling study. Hered Cancer Clin Pract 2016;14:12. [PMID: 27252788 DOI: 10.1186/s13053-016-0052-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
15 Kesselheim A, Ashton E, Bockenhauer D. Potential and pitfalls in the genetic diagnosis of kidney diseases. Clin Kidney J 2017;10:581-5. [PMID: 28980668 DOI: 10.1093/ckj/sfx075] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
16 Sukhai MA, Craddock KJ, Thomas M, Hansen AR, Zhang T, Siu L, Bedard P, Stockley TL, Kamel-reid S. A classification system for clinical relevance of somatic variants identified in molecular profiling of cancer. Genet Med 2016;18:128-36. [DOI: 10.1038/gim.2015.47] [Cited by in Crossref: 55] [Cited by in F6Publishing: 56] [Article Influence: 7.9] [Reference Citation Analysis]
17 Henderson GE, Wolf SM, Kuczynski KJ, Joffe S, Sharp RR, Parsons DW, Knoppers BM, Yu JH, Appelbaum PS. The challenge of informed consent and return of results in translational genomics: empirical analysis and recommendations. J Law Med Ethics 2014;42:344-55. [PMID: 25264092 DOI: 10.1111/jlme.12151] [Cited by in Crossref: 48] [Cited by in F6Publishing: 45] [Article Influence: 8.0] [Reference Citation Analysis]
18 Swanson K, Sparks TN, Lianoglou BR, Chen F, Downum S, Patel S, Rego S, Yip T, Van Ziffle J, Koenig BA, Slavotinek AM, Norton ME. Preference for secondary findings in prenatal and pediatric exome sequencing. Prenat Diagn 2021. [PMID: 34057224 DOI: 10.1002/pd.5973] [Reference Citation Analysis]
19 Yu JH, Appelbaum PS, Brothers KB, Joffe S, Kauffman TL, Koenig BA, Prince AE, Scollon S, Wolf SM, Bernhardt BA, Wilfond BS; Clinical Sequencing Exploratory Research (CSER) Consortium Informed Consent and Governance Working Group. Consent for clinical genome sequencing: considerations from the Clinical Sequencing Exploratory Research Consortium. Per Med 2019;16:325-33. [PMID: 31313633 DOI: 10.2217/pme-2018-0076] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
20 Dal-Ré R, Katsanis N, Katsanis S, Parker LS, Ayuso C. Managing incidental genomic findings in clinical trials: fulfillment of the principle of justice. PLoS Med 2014;11:e1001584. [PMID: 24453945 DOI: 10.1371/journal.pmed.1001584] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
21 Jarvik GP, Amendola LM, Berg JS, Brothers K, Clayton EW, Chung W, Evans BJ, Evans JP, Fullerton SM, Gallego CJ, Garrison NA, Gray SW, Holm IA, Kullo IJ, Lehmann LS, McCarty C, Prows CA, Rehm HL, Sharp RR, Salama J, Sanderson S, Van Driest SL, Williams MS, Wolf SM, Wolf WA, Burke W; eMERGE Act-ROR Committee and CERC Committee., CSER Act-ROR Working Group. Return of genomic results to research participants: the floor, the ceiling, and the choices in between. Am J Hum Genet 2014;94:818-26. [PMID: 24814192 DOI: 10.1016/j.ajhg.2014.04.009] [Cited by in Crossref: 244] [Cited by in F6Publishing: 220] [Article Influence: 30.5] [Reference Citation Analysis]
22 Zawati MH, Parry D, Knoppers BM. The best interests of the child and the return of results in genetic research: international comparative perspectives. BMC Med Ethics 2014;15:72. [PMID: 25280986 DOI: 10.1186/1472-6939-15-72] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
23 Van Driest SL, Wells QS, Stallings S, Bush WS, Gordon A, Nickerson DA, Kim JH, Crosslin DR, Jarvik GP, Carrell DS, Ralston JD, Larson EB, Bielinski SJ, Olson JE, Ye Z, Kullo IJ, Abul-Husn NS, Scott SA, Bottinger E, Almoguera B, Connolly J, Chiavacci R, Hakonarson H, Rasmussen-Torvik LJ, Pan V, Persell SD, Smith M, Chisholm RL, Kitchner TE, He MM, Brilliant MH, Wallace JR, Doheny KF, Shoemaker MB, Li R, Manolio TA, Callis TE, Macaya D, Williams MS, Carey D, Kapplinger JD, Ackerman MJ, Ritchie MD, Denny JC, Roden DM. Association of Arrhythmia-Related Genetic Variants With Phenotypes Documented in Electronic Medical Records. JAMA 2016;315:47-57. [PMID: 26746457 DOI: 10.1001/jama.2015.17701] [Cited by in Crossref: 118] [Cited by in F6Publishing: 106] [Article Influence: 19.7] [Reference Citation Analysis]
24 Hehir-Kwa JY, Claustres M, Hastings RJ, van Ravenswaaij-Arts C, Christenhusz G, Genuardi M, Melegh B, Cambon-Thomsen A, Patsalis P, Vermeesch J, Cornel MC, Searle B, Palotie A, Capoluongo E, Peterlin B, Estivill X, Robinson PN. Towards a European consensus for reporting incidental findings during clinical NGS testing. Eur J Hum Genet 2015;23:1601-6. [PMID: 26036857 DOI: 10.1038/ejhg.2015.111] [Cited by in Crossref: 62] [Cited by in F6Publishing: 51] [Article Influence: 8.9] [Reference Citation Analysis]
25 Wynn J. Genomic Testing: a Genetic Counselor's Personal Reflection on Three Years of Consenting and Testing. J Genet Couns 2016;25:691-7. [PMID: 26242468 DOI: 10.1007/s10897-015-9868-y] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
26 Kaphingst KA, Ivanovich J, Biesecker BB, Dresser R, Seo J, Dressler LG, Goodfellow PJ, Goodman MS. Preferences for return of incidental findings from genome sequencing among women diagnosed with breast cancer at a young age. Clin Genet 2016;89:378-84. [PMID: 25871653 DOI: 10.1111/cge.12597] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 4.9] [Reference Citation Analysis]
27 Lázaro-Muñoz G, Farrell MS, Crowley JJ, Filmyer DM, Shaughnessy RA, Josiassen RC, Sullivan PF. Improved ethical guidance for the return of results from psychiatric genomics research. Mol Psychiatry 2018;23:15-23. [PMID: 29158581 DOI: 10.1038/mp.2017.228] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 4.4] [Reference Citation Analysis]
28 Blackburn HL, Schroeder B, Turner C, Shriver CD, Ellsworth DL, Ellsworth RE. Management of Incidental Findings in the Era of Next-generation Sequencing. Curr Genomics 2015;16:159-74. [PMID: 26069456 DOI: 10.2174/1389202916666150317232930] [Cited by in Crossref: 33] [Cited by in F6Publishing: 25] [Article Influence: 4.7] [Reference Citation Analysis]
29 Ethics Committee of the American Society for Reproductive Medicine. Electronic address: asrm@asrm.org., Ethics Committee of the American Society for Reproductive Medicine. Disclosure of sex when incidentally revealed as part of preimplantation genetic testing (PGT): an Ethics Committee opinion. Fertil Steril 2018;110:625-7. [PMID: 30196948 DOI: 10.1016/j.fertnstert.2018.06.019] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
30 Green RC, Goddard KAB, Jarvik GP, Amendola LM, Appelbaum PS, Berg JS, Bernhardt BA, Biesecker LG, Biswas S, Blout CL, Bowling KM, Brothers KB, Burke W, Caga-Anan CF, Chinnaiyan AM, Chung WK, Clayton EW, Cooper GM, East K, Evans JP, Fullerton SM, Garraway LA, Garrett JR, Gray SW, Henderson GE, Hindorff LA, Holm IA, Lewis MH, Hutter CM, Janne PA, Joffe S, Kaufman D, Knoppers BM, Koenig BA, Krantz ID, Manolio TA, McCullough L, McEwen J, McGuire A, Muzny D, Myers RM, Nickerson DA, Ou J, Parsons DW, Petersen GM, Plon SE, Rehm HL, Roberts JS, Robinson D, Salama JS, Scollon S, Sharp RR, Shirts B, Spinner NB, Tabor HK, Tarczy-Hornoch P, Veenstra DL, Wagle N, Weck K, Wilfond BS, Wilhelmsen K, Wolf SM, Wynn J, Yu JH; CSER Consortium. Clinical Sequencing Exploratory Research Consortium: Accelerating Evidence-Based Practice of Genomic Medicine. Am J Hum Genet 2016;98:1051-66. [PMID: 27181682 DOI: 10.1016/j.ajhg.2016.04.011] [Cited by in Crossref: 96] [Cited by in F6Publishing: 89] [Article Influence: 16.0] [Reference Citation Analysis]
31 Hamm JA, Mikhail FM, Hollenbeck D, Farmer M, Robin NH. Incidental Detection of Cancer Predisposition Gene Copy Number Variations by Array Comparative Genomic Hybridization. The Journal of Pediatrics 2014;165:1057-1059.e4. [DOI: 10.1016/j.jpeds.2014.07.042] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
32 Madadi P. Ethical perspectives on translational pharmacogenetic research involving children. Paediatr Drugs 2015;17:91-5. [PMID: 25504355 DOI: 10.1007/s40272-014-0111-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
33 Appelbaum PS, Fyer A, Klitzman RL, Martinez J, Parens E, Zhang Y, Chung WK. Researchers' views on informed consent for return of secondary results in genomic research. Genet Med 2015;17:644-50. [PMID: 25503499 DOI: 10.1038/gim.2014.163] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
34 Evans BJ. Minimizing liability risks under the ACMG recommendations for reporting incidental findings in clinical exome and genome sequencing. Genet Med 2013;15:915-20. [PMID: 24030435 DOI: 10.1038/gim.2013.135] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 2.9] [Reference Citation Analysis]
35 Richer J, Laberge A. Secondary findings from next-generation sequencing: what does actionable in childhood really mean? Genet Med 2019;21:124-32. [DOI: 10.1038/s41436-018-0034-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
36 Ormond KE, O'daniel JM, Kalia SS. Secondary findings: How did we get here, and where are we going? J Genet Couns 2019;28:326-33. [DOI: 10.1002/jgc4.1098] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 5.7] [Reference Citation Analysis]
37 Devon KM, Lerner-ellis JP, Ganai S, Angelos P. Ethics and genomic medicine, how to navigate decisions in surgical oncology: Ethics and Genomic Medicine in Surgical Oncology. J Surg Oncol 2015;111:18-23. [DOI: 10.1002/jso.23771] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
38 Westerfield L, Darilek S, van den Veyver IB. Counseling Challenges with Variants of Uncertain Significance and Incidental Findings in Prenatal Genetic Screening and Diagnosis. J Clin Med 2014;3:1018-32. [PMID: 26237491 DOI: 10.3390/jcm3031018] [Cited by in Crossref: 44] [Cited by in F6Publishing: 38] [Article Influence: 5.5] [Reference Citation Analysis]
39 Ahn J, Ogilvie C. Context and Applications of Targeted Genetic Testing, with Emphasis on Copy Number Variants. Elsevier; 2016. pp. 33-51. [DOI: 10.1016/bs.acc.2016.03.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
40 Savatt JM, Myers SM. Genetic Testing in Neurodevelopmental Disorders. Front Pediatr 2021;9:526779. [PMID: 33681094 DOI: 10.3389/fped.2021.526779] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
41 Boardman F, Hale R. Responsibility, identity, and genomic sequencing: A comparison of published recommendations and patient perspectives on accepting or declining incidental findings. Mol Genet Genomic Med 2018;6:1079-96. [PMID: 30370638 DOI: 10.1002/mgg3.485] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
42 van den Berg S, Shen Y, Jones SJ, Gibson WT. Genetic counseling in direct-to-consumer exome sequencing: a case report. J Genet Couns 2014;23:742-53. [PMID: 24954083 DOI: 10.1007/s10897-014-9737-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
43 Hamilton JG, Edwards HM, Khoury MJ, Taplin SH. Cancer screening and genetics: a tale of two paradigms. Cancer Epidemiol Biomarkers Prev 2014;23:909-16. [PMID: 24706727 DOI: 10.1158/1055-9965.EPI-13-1016] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
44 Olgiati S, Quadri M, Bonifati V. Genetics of movement disorders in the next-generation sequencing era: NGS in Movement Disorders. Mov Disord 2016;31:458-70. [DOI: 10.1002/mds.26521] [Cited by in Crossref: 28] [Cited by in F6Publishing: 18] [Article Influence: 4.7] [Reference Citation Analysis]
45 Balcom JR, Kotzer KE, Waltman LA, Kemppainen JL, Thomas BC. The Genetic Counselor’s Role in Managing Ethical Dilemmas Arising in the Laboratory Setting. J Genet Counsel 2016;25:838-54. [DOI: 10.1007/s10897-016-9957-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
46 Pinard A, Miltgen M, Blanchard A, Mathieu H, Desvignes JP, Salgado D, Fabre A, Arnaud P, Barré L, Krahn M, Grandval P, Olschwang S, Zaffran S, Boileau C, Béroud C, Collod-Béroud G. Actionable Genes, Core Databases, and Locus-Specific Databases. Hum Mutat 2016;37:1299-307. [PMID: 27600092 DOI: 10.1002/humu.23112] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
47 Bui TH, Raymond FL, Van den Veyver IB. Current controversies in prenatal diagnosis 2: should incidental findings arising from prenatal testing always be reported to patients? Prenat Diagn 2014;34:12-7. [PMID: 24214820 DOI: 10.1002/pd.4275] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
48 Bombard Y, Clausen M, Mighton C, Carlsson L, Casalino S, Glogowski E, Schrader K, Evans M, Scheer A, Baxter N, Hamilton JG, Lerner-Ellis J, Offit K, Robson M, Laupacis A. The Genomics ADvISER: development and usability testing of a decision aid for the selection of incidental sequencing results. Eur J Hum Genet 2018;26:984-95. [PMID: 29703952 DOI: 10.1038/s41431-018-0144-0] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 5.5] [Reference Citation Analysis]
49 Hamilton JG, Shuk E, Genoff MC, Rodríguez VM, Hay JL, Offit K, Robson ME. Interest and Attitudes of Patients With Advanced Cancer With Regard to Secondary Germline Findings From Tumor Genomic Profiling. J Oncol Pract 2017;13:e590-601. [PMID: 28628391 DOI: 10.1200/JOP.2016.020057] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 3.2] [Reference Citation Analysis]
50 Kulchak Rahm A, Bailey L, Fultz K, Fan A, Williams JL, Buchanan A, Davis FD, Murray MF, Williams MS. Parental attitudes and expectations towards receiving genomic test results in healthy children. Transl Behav Med 2018;8:44-53. [PMID: 29385584 DOI: 10.1093/tbm/ibx044] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
51 Valente EM, Nuovo S, Doherty D. Genetics of cerebellar disorders. Handb Clin Neurol 2018;154:267-86. [PMID: 29903444 DOI: 10.1016/B978-0-444-63956-1.00016-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
52 Shah N, Hou YC, Yu HC, Sainger R, Caskey CT, Venter JC, Telenti A. Identification of Misclassified ClinVar Variants via Disease Population Prevalence. Am J Hum Genet 2018;102:609-19. [PMID: 29625023 DOI: 10.1016/j.ajhg.2018.02.019] [Cited by in Crossref: 72] [Cited by in F6Publishing: 52] [Article Influence: 18.0] [Reference Citation Analysis]
53 Eichinger J, Elger BS, Koné I, Filges I, Shaw D, Zimmermann B, McLennan S. The full spectrum of ethical issues in pediatric genome-wide sequencing: a systematic qualitative review. BMC Pediatr 2021;21:387. [PMID: 34488686 DOI: 10.1186/s12887-021-02830-w] [Reference Citation Analysis]
54 Clayton EW, McCullough LB, Biesecker LG, Joffe S, Ross LF, Wolf SM; Clinical Sequencing Exploratory Research (CSER) Consortium Pediatrics Working Group. Addressing the ethical challenges in genetic testing and sequencing of children. Am J Bioeth 2014;14:3-9. [PMID: 24592828 DOI: 10.1080/15265161.2013.879945] [Cited by in Crossref: 71] [Cited by in F6Publishing: 62] [Article Influence: 8.9] [Reference Citation Analysis]
55 Yu JH, Harrell TM, Jamal SM, Tabor HK, Bamshad MJ. Attitudes of genetics professionals toward the return of incidental results from exome and whole-genome sequencing. Am J Hum Genet 2014;95:77-84. [PMID: 24975944 DOI: 10.1016/j.ajhg.2014.06.004] [Cited by in Crossref: 89] [Cited by in F6Publishing: 81] [Article Influence: 11.1] [Reference Citation Analysis]
56 Bope CD, Chimusa ER, Nembaware V, Mazandu GK, de Vries J, Wonkam A. Dissecting in silico Mutation Prediction of Variants in African Genomes: Challenges and Perspectives. Front Genet 2019;10:601. [PMID: 31293624 DOI: 10.3389/fgene.2019.00601] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
57 Freed AS, Gruß I, McMullen CK, Leo MC, Kauffman TL, Porter KM, Muessig KR, Eubanks D, Goddard KAB, Wilfond BS, Liles EG. A decision aid for additional findings in genomic sequencing: Development and pilot testing. Patient Educ Couns 2021;104:960-8. [PMID: 33191058 DOI: 10.1016/j.pec.2020.10.038] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
58 Olfson E, Cottrell CE, Davidson NO, Gurnett CA, Heusel JW, Stitziel NO, Chen LS, Hartz S, Nagarajan R, Saccone NL, Bierut LJ. Identification of Medically Actionable Secondary Findings in the 1000 Genomes. PLoS One 2015;10:e0135193. [PMID: 26332594 DOI: 10.1371/journal.pone.0135193] [Cited by in Crossref: 52] [Cited by in F6Publishing: 48] [Article Influence: 7.4] [Reference Citation Analysis]
59 Wynn J, Martinez J, Duong J, Zhang Y, Phelan J, Fyer A, Klitzman R, Appelbaum PS, Chung WK. Association of Researcher Characteristics with Views on Return of Incidental Findings from Genomic Research. J Genet Couns 2015;24:833-41. [PMID: 25592144 DOI: 10.1007/s10897-014-9817-1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
60 Grubs RE, Parker LS, Hamilton R. Subtle Psychosocial Sequelae of Genetic Test Results. Curr Genet Med Rep 2014;2:242-9. [DOI: 10.1007/s40142-014-0053-7] [Cited by in Crossref: 3] [Article Influence: 0.4] [Reference Citation Analysis]
61 Strong KA, Zusevics KL, Bick D, Veith R. Views of primary care providers regarding the return of genome sequencing incidental findings. Clin Genet 2014;86:461-8. [PMID: 24673592 DOI: 10.1111/cge.12390] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
62 Roberts KA, Mao R, O’fallon BD, Lyon E. Reporting of Clinical Genomics Test Results. Clinical Genomics. Elsevier; 2015. pp. 217-29. [DOI: 10.1016/b978-0-12-404748-8.00013-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
63 Kleiderman E, Knoppers BM, Fernandez CV, Boycott KM, Ouellette G, Wong-Rieger D, Adam S, Richer J, Avard D. Returning incidental findings from genetic research to children: views of parents of children affected by rare diseases. J Med Ethics 2014;40:691-6. [PMID: 24356209 DOI: 10.1136/medethics-2013-101648] [Cited by in Crossref: 53] [Cited by in F6Publishing: 53] [Article Influence: 5.9] [Reference Citation Analysis]
64 Clayton EW. How Much Control Do Children and Adolescents Have over Genomic Testing, Parental Access to Their Results, and Parental Communication of Those Results to Others? J Law Med Ethics 2015;43:538-44. [PMID: 26479563 DOI: 10.1111/jlme.12296] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
65 Smith LA, Douglas J, Braxton AA, Kramer K. Reporting Incidental Findings in Clinical Whole Exome Sequencing: Incorporation of the 2013 ACMG Recommendations into Current Practices of Genetic Counseling. J Genet Couns 2015;24:654-62. [PMID: 25403901 DOI: 10.1007/s10897-014-9794-4] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 3.1] [Reference Citation Analysis]
66 Yu JH, Crouch J, Jamal SM, Bamshad MJ, Tabor HK. Attitudes of non-African American focus group participants toward return of results from exome and whole genome sequencing. Am J Med Genet A 2014;164A:2153-60. [PMID: 24845082 DOI: 10.1002/ajmg.a.36610] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 4.5] [Reference Citation Analysis]
67 Wolf SM, Burke W, Koenig BA. Mapping the Ethics of Translational Genomics: Situating Return of Results and Navigating the Research-Clinical Divide. J Law Med Ethics 2015;43:486-501. [PMID: 26479558 DOI: 10.1111/jlme.12291] [Cited by in Crossref: 16] [Cited by in F6Publishing: 27] [Article Influence: 3.2] [Reference Citation Analysis]
68 Ding LE, Burnett L, Chesher D. The impact of reporting incidental findings from exome and whole-genome sequencing: predicted frequencies based on modeling. Genet Med 2015;17:197-204. [PMID: 25077650 DOI: 10.1038/gim.2014.94] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.9] [Reference Citation Analysis]
69 Wong CS, Kogon AJ, Warady BA, Furth SL, Lantos JD, Wilfond BS. Ethical and Policy Considerations for Genomic Testing in Pediatric Research: The Path Toward Disclosing Individual Research Results. Am J Kidney Dis 2019;73:837-45. [PMID: 30879919 DOI: 10.1053/j.ajkd.2019.01.020] [Reference Citation Analysis]
70 Saelaert M, Mertes H, De Baere E, Devisch I. Incidental or secondary findings: an integrative and patient-inclusive approach to the current debate. Eur J Hum Genet 2018;26:1424-31. [PMID: 29970927 DOI: 10.1038/s41431-018-0200-9] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
71 Lázaro-Muñoz G. The fiduciary relationship model for managing clinical genomic "incidental" findings. J Law Med Ethics 2014;42:576-89. [PMID: 25565622 DOI: 10.1111/jlme.12177] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
72 Gornick MC, Ryan KA, Scherer AM, Scott Roberts J, De Vries RG, Uhlmann WR. Interpretations of the Term "Actionable" when Discussing Genetic Test Results: What you Mean Is Not What I Heard. J Genet Couns 2019;28:334-42. [PMID: 30964581 DOI: 10.1007/s10897-018-0289-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
73 Ortiz-Osorno AB, Ehler LA, Brooks J. Considering Actionability at the Participant's Research Setting Level for Anticipatable Incidental Findings from Clinical Research. J Law Med Ethics 2015;43:619-32. [PMID: 26479571 DOI: 10.1111/jlme.12304] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
74 Fisher E, Achilles S, Tönnies H, Schmidtke J. [Concepts for the return of secondary genetic findings in medical diagnostics and research]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2015;58:166-73. [PMID: 25487853 DOI: 10.1007/s00103-014-2096-z] [Reference Citation Analysis]
75 Wolf SM, Ossorio PN, Berry SA, Greely HT, McGuire AL, Penny MA, Terry SF; LawSeq Framework Task Force. Integrating Rules for Genomic Research, Clinical Care, Public Health Screening and DTC Testing: Creating Translational Law for Translational Genomics. J Law Med Ethics 2020;48:69-86. [PMID: 32342790 DOI: 10.1177/1073110520916996] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
76 Ryan KA, De Vries RG, Uhlmann WR, Roberts JS, Gornick MC. Public's Views toward Return of Secondary Results in Genomic Sequencing: It's (Almost) All about the Choice. J Genet Couns 2017;26:1197-212. [PMID: 28357777 DOI: 10.1007/s10897-017-0095-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
77 Berkman BE, Hull SC. The "right not to know" in the genomic era: time to break from tradition? Am J Bioeth 2014;14:28-31. [PMID: 24592837 DOI: 10.1080/15265161.2014.880313] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
78 Knoppers BM, Zawati MH, Sénécal K. Return of genetic testing results in the era of whole-genome sequencing. Nat Rev Genet 2015;16:553-9. [PMID: 26239711 DOI: 10.1038/nrg3960] [Cited by in Crossref: 98] [Cited by in F6Publishing: 88] [Article Influence: 14.0] [Reference Citation Analysis]
79 Winkler EC, Wiemann S. Findings made in gene panel to whole genome sequencing: data, knowledge, ethics – and consequences? Expert Review of Molecular Diagnostics 2016;16:1259-70. [DOI: 10.1080/14737159.2016.1212662] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
80 Myers MF, Martin LJ, Prows CA. Adolescents' and Parents' Genomic Testing Decisions: Associations With Age, Race, and Sex. J Adolesc Health 2020;66:288-95. [PMID: 31685375 DOI: 10.1016/j.jadohealth.2019.08.028] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
81 Braverman G, Shapiro ZE, Bernstein JA. Ethical Issues in Contemporary Clinical Genetics. Mayo Clin Proc Innov Qual Outcomes 2018;2:81-90. [PMID: 30225437 DOI: 10.1016/j.mayocpiqo.2018.03.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
82 Ulm E, Feero WG, Dineen R, Charrow J, Wicklund C. Genetics professionals' opinions of whole-genome sequencing in the newborn period. J Genet Couns 2015;24:452-63. [PMID: 25348082 DOI: 10.1007/s10897-014-9779-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
83 Hunter JE, Irving SA, Biesecker LG, Buchanan A, Jensen B, Lee K, Martin CL, Milko L, Muessig K, Niehaus AD, O'Daniel J, Piper MA, Ramos EM, Schully SD, Scott AF, Slavotinek A, Sobreira N, Strande N, Weaver M, Webber EM, Williams MS, Berg JS, Evans JP, Goddard KA. A standardized, evidence-based protocol to assess clinical actionability of genetic disorders associated with genomic variation. Genet Med 2016;18:1258-68. [PMID: 27124788 DOI: 10.1038/gim.2016.40] [Cited by in Crossref: 59] [Cited by in F6Publishing: 57] [Article Influence: 9.8] [Reference Citation Analysis]
84 Fossey R, Kochan D, Winkler E, Pacyna JE, Olson J, Thibodeau S, Connolly JJ, Harr M, Behr MA, Prows CA, Cobb B, Myers MF, Leslie ND, Namjou-Khales B, Milo Rasouly H, Wynn J, Fedotov A, Chung WK, Gharavi A, Williams JL, Pais L, Holm I, Aufox S, Smith ME, Scrol A, Leppig K, Jarvik GP, Wiesner GL, Li R, Stroud M, Smoller JW, Sharp RR, Kullo IJ. Ethical Considerations Related to Return of Results from Genomic Medicine Projects: The eMERGE Network (Phase III) Experience. J Pers Med 2018;8:E2. [PMID: 29301385 DOI: 10.3390/jpm8010002] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 7.3] [Reference Citation Analysis]
85 [DOI: 10.1101/075416] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
86 Johnston J, Lantos JD, Goldenberg A, Chen F, Parens E, Koenig BA; members of the NSIGHT Ethics and Policy Advisory Board. Sequencing Newborns: A Call for Nuanced Use of Genomic Technologies. Hastings Cent Rep 2018;48 Suppl 2:S2-6. [PMID: 30133723 DOI: 10.1002/hast.874] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 10.3] [Reference Citation Analysis]
87 Mallawaarachchi A, Collins F. Testing the Complex Child: CGH Array, WES, Clinical Exome, WGS. Curr Pediatr Rep 2016;4:155-63. [DOI: 10.1007/s40124-016-0111-6] [Reference Citation Analysis]
88 Janvier A, Farlow B. Arrogance-Based Medicine: Guidelines Regarding Genetic Testing in Children. The American Journal of Bioethics 2014;14:15-6. [DOI: 10.1080/15265161.2013.879951] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
89 Kreiman BL, Boles RG. State of the Art of Genetic Testing for Patients With Autism: A Practical Guide for Clinicians. Semin Pediatr Neurol 2020;34:100804. [PMID: 32446438 DOI: 10.1016/j.spen.2020.100804] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
90 Wolf SM. The Continuing Evolution of Ethical Standards for Genomic Sequencing in Clinical Care: Restoring Patient Choice. J Law Med Ethics 2017;45:333-40. [PMID: 30100701 DOI: 10.1177/1073110517737531] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
91 Katz AE, Nussbaum RL, Solomon BD, Rehm HL, Williams MS, Biesecker LG. Management of Secondary Genomic Findings. Am J Hum Genet 2020;107:3-14. [PMID: 32619490 DOI: 10.1016/j.ajhg.2020.05.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
92 Uhlmann WR, Roberts JS. Ethical issues in neurogenetics. Handb Clin Neurol 2018;147:23-36. [PMID: 29325614 DOI: 10.1016/B978-0-444-63233-3.00003-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]